At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...

Incyte's data bolster efforts to develop a new type of drug for myelofibrosis, and suggest it may be a replacement for Jakafi ...

A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...

Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...

At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, ...

The Advisory Committee on Immunization Practices' (ACIP) meetings used to be a geek’s dream: hours of long, maybe dreary ...

The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major ...

Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through ...

AI use has exploded in radiology as the field struggles with staffing shortages, exacerbated by growing imaging volumes.